FOXM1 has been implicated in estrogen signaling in ER+ BC cells, in which FOXM1 is a transcriptional target of ERα and plays a critical role in the sensitivity and resistance to endocrine (anti-estrogen) therapy in breast cancer [71]. The gene discussed is ESR1; the disease is breast carcinoma.